BR9712307A - Pirazolinonas para o tratamento de potência enfraquecida - Google Patents

Pirazolinonas para o tratamento de potência enfraquecida

Info

Publication number
BR9712307A
BR9712307A BR9712307-2A BR9712307A BR9712307A BR 9712307 A BR9712307 A BR 9712307A BR 9712307 A BR9712307 A BR 9712307A BR 9712307 A BR9712307 A BR 9712307A
Authority
BR
Brazil
Prior art keywords
treatment
weakened
potency
pyrazolinones
pirazolinones
Prior art date
Application number
BR9712307-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Michael Arlt
Rochus Jonas
Pierre Schelling
Maria Christaldler
Franz-Werner Kluxen
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9712307A publication Critical patent/BR9712307A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9712307-2A 1996-10-14 1997-10-08 Pirazolinonas para o tratamento de potência enfraquecida BR9712307A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19642284A DE19642284A1 (de) 1996-10-14 1996-10-14 Pyrazolinone zur Behandlung von Potenzstörungen
PCT/EP1997/005532 WO1998016224A1 (de) 1996-10-14 1997-10-08 Pyrazolinone zur behandlung von potenzstörungen

Publications (1)

Publication Number Publication Date
BR9712307A true BR9712307A (pt) 1999-08-31

Family

ID=7808669

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712307-2A BR9712307A (pt) 1996-10-14 1997-10-08 Pirazolinonas para o tratamento de potência enfraquecida

Country Status (14)

Country Link
EP (1) EP0930881A1 (no)
JP (1) JP2001501958A (no)
KR (1) KR20000049086A (no)
CN (1) CN1233178A (no)
AR (1) AR008494A1 (no)
AU (1) AU4945297A (no)
BR (1) BR9712307A (no)
CA (1) CA2268823A1 (no)
DE (1) DE19642284A1 (no)
HU (1) HUP0000233A3 (no)
NO (1) NO991734L (no)
PL (1) PL332821A1 (no)
WO (1) WO1998016224A1 (no)
ZA (1) ZA979151B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
DE19518082A1 (de) * 1995-05-17 1996-11-21 Merck Patent Gmbh 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one

Also Published As

Publication number Publication date
EP0930881A1 (de) 1999-07-28
HUP0000233A3 (en) 2001-06-28
JP2001501958A (ja) 2001-02-13
WO1998016224A1 (de) 1998-04-23
ZA979151B (en) 1998-05-11
AR008494A1 (es) 2000-01-19
PL332821A1 (en) 1999-10-11
CA2268823A1 (en) 1998-04-23
AU4945297A (en) 1998-05-11
CN1233178A (zh) 1999-10-27
DE19642284A1 (de) 1998-04-16
NO991734D0 (no) 1999-04-13
HUP0000233A2 (hu) 2001-04-28
NO991734L (no) 1999-04-13
KR20000049086A (ko) 2000-07-25

Similar Documents

Publication Publication Date Title
BR9908020A (pt) Fórmula para polimento ótico
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
BR9806752A (pt) Ftalazinonas.
BR9805544C1 (pt) Uso de um composto.
BR0109703A (pt) Derivados de piperazina
BR9812753A (pt) Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
BR9914978A (pt) Estabilização de produtos de cuidados do corpo e domésticos
ATE231872T1 (de) Thiazolopyrimidinderivate
IT1285770B1 (it) Composti corticoidei
EP0793489A4 (en) AGENTS FOR TREATING SKIN DISEASES
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR9814885A (pt) Combinação de um inibidor da enzima de conversão da angiotensina e de um diurético para o tratamento das desordens microcirculatórias
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
BR9910032A (pt) Tienopirimidinas
AU7162387A (en) Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
BR0012327A (pt) Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
BR9714049A (pt) Imidazopiridazinas
DE69626987D1 (de) Pharmaceutische komposition

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]